Filing Flows › Sanara MedTech (SMTI) › Who owns the stock
Who owns Sanara MedTech (SMTI) stock
70 funds reported Sanara MedTech (SMTI) shares in their latest 13F filings, worth $52.6M in all. The largest holder is BlackRock ($5.9M). Last quarter 41 funds added to their stakes and 16 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| BlackRock | 248,827 | $5.9M | increase | 2026-06-30 |
| Transmarket Holdings LP | 148,956 | $5.2M | new | 2026-09-30 |
| ABC Arbitrage SA | 140,894 | $5.0M | new | 2026-09-30 |
| Vanguard Capital Management LLC | 194,897 | $4.6M | increase | 2026-06-30 |
| Vanguard Group | 183,137 | $4.3M | increase | 2025-12-31 |
| Royal Bank of Canada | 130,995 | $3.1M | decrease | 2026-06-30 |
| AQR Capital Management LLC | 112,207 | $2.6M | increase | 2026-06-30 |
| Geode Capital Management, LLC | 89,179 | $2.1M | increase | 2026-06-30 |
| Goldman Sachs Group | 74,198 | $1.8M | increase | 2026-06-30 |
| Renaissance Technologies LLC | 67,400 | $1.6M | increase | 2026-06-30 |
| State Street | 63,469 | $1.5M | increase | 2026-06-30 |
| Squarepoint Ops LLC | 53,811 | $1.3M | decrease | 2026-06-30 |
| Jane Street Group, LLC | 50,806 | $1.2M | increase | 2026-06-30 |
| Marshall Wace, LLP | 49,457 | $1.2M | decrease | 2026-06-30 |
| Citadel Advisors LLC | 36,813 | $868K | increase | 2026-06-30 |
Sanara MedTech's latest quarter
Sanara MedTech, Q2 2026: revenue $28.1M (+9% year over year), operating margin 6.3%, net loss $453K, operating cash flow $2.0M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most SMTI stock?
By the latest 13F filings: BlackRock ($5.9M); Transmarket Holdings LP ($5.2M); ABC Arbitrage SA ($5.0M); Vanguard Capital Management LLC ($4.6M); Vanguard Group ($4.3M).
What is the short interest in SMTI?
374,810 shares were sold short at the 2026-10-15 settlement, 5.72% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.